ANKRIN THERAPEUTICS

Ankrin Therapeutics is developing inhibitors against essential protein-protein interactions required for homologous recombination repair of toxic DNA lesions. Our drug discovery pipeline combines both structure-based drug design and high-throughput screening strategies... Ankrin Therapeutics is a biotech start-up developing first-in-class drugs for cancer treatment. Our novel and unique therapeutic strategies, founded on forefront high quality research in cancer biology, target essential protein-protein interactions required for error-free DNA damage repair... Ankrin Therapeutics aims to create innovation in precision oncology by exploiting inherent DNA repair dependencies. We will leverage novel, proprietary, and well-characterized protein targets to develop first-in-class drugs against homologous recombination.

Also known as: Ankrin Therapeutics ApS

Primary location: København